⌘K

Login Start Free

Home/Filings/4/0001455244-09-000130

4//SEC Filing

DAVIS PETER B 4

Accession 0001455244-09-000130

CIK 0000072444other

View on SEC.gov Company Profile

Filed

Nov 24, 7:00 PM ET

Accepted

Nov 25, 12:58 PM ET

Size

6.4 KB

Accession

0001455244-09-000130

Insider Transaction Report

Form 4

Period: 2009-11-23

NABI BIOPHARMACEUTICALSNABI

Director

Transactions

Purchase
Common stock
2009-11-23$4.98/sh+800$3,983→ 8,614 total
Purchase
Common stock
2009-11-23$4.98/sh+2,200$10,956→ 10,814 total

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

NABI BIOPHARMACEUTICALS

CIK 0000072444

Entity typeother

Related Parties

1

filerCIK 0001222789

Filing Metadata

Form type: 4
Filed: Nov 24, 7:00 PM ET
Accepted: Nov 25, 12:58 PM ET
Size: 6.4 KB

View on SEC.gov